Abstract
Observational studies have suggested a link between selective serotonin reuptake inhibitors (SSRIs) and excess risk for adverse cardiovascular (CV) events in older adults (age, ≥65); whether this is true in younger adults is unclear. Furthermore, the FDA has warned against prescribing the SSRI citalopram at doses >40 mg daily because of risk for QT-interval prolongation. U.K. researchers …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
